Recent advances in materials for extended-release antibiotic delivery system

Journal of Antibiotics

Volumn 64, Issue 9, 2011, Pages 625-634

  Gao, Ping ^a   Nie, Xin ^a   Zou, Meijuan ^a   Shi, Yijie ^a   Cheng, Gang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

antibiotic resistance; coating material; complex; extended release; matrix material; nanoparticles

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMOXICILLIN PULSYS; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; ARIKACE; AZITHROMYCIN; BIOMATERIAL; CEFACLOR; CEFAZOLIN; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; DOXORUBICIN; GENTAMICIN; HYDROXYPROPYLMETHYLCELLULOSE; LEVOFLOXACIN; MINOCYCLINE; NANOCARRIER; NANOPARTICLE; NORFLOXACIN; POLYMER; RIFAMPICIN; SPARFLOXACIN; TEICOPLANIN; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BIOCOMPATIBILITY; BIODEGRADATION; CHEMICAL MODIFICATION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; EXTENDED DRUG RELEASE; HYDROPHILICITY; NANOTECHNOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SHELF LIFE; SUSTAINED DRUG RELEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, BACTERIAL; HALF-LIFE; HUMANS; MEDICATION ADHERENCE; MICROBIAL SENSITIVITY TESTS; NANOPARTICLES; TIME FACTORS;

EID: 80053364035     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2011.58     Document Type: Review

References (89)

1. Blasi, F., Aliberti, S. &Tarsia, P. Clinical applications of azithromycin microspheres in respiratory tract infections. Int. J. Nanomedicine 2, 551-559 (2007).
2. Jacobs, M. R. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin. Microbiol. Infect. 7, 589-596 (2001). (Pubitemid 34960355)
3. Drusano, G. L. Role of pharmacokinetics in the outcome of infections. Antimicrob. Agents Chemother. 32, 289-297 (1988). (Pubitemid 18063550)
4. Turnidge, J. D. The pharmacodynamics of beta-lactams. Clin. Infect. Dis. 27, 10-22 (1998).
5. Roberts, J. A., Lipman, J., Blot, S. &Rello, J. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients? Curr. Opin. Crit. Care 14, 390-396 (2008).
6. Roberts, J. A., Paratz, J., Paratz, E., Krueger, W. A. &Lipman, J. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Int. J. Antimicrob. Agents 30, 11-18 (2007). (Pubitemid 46874893)
7. Moriyama, B., Henning, S. A., Neuhauser, M. M., Danner, R. L. &Walsh, T. J. Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria. Ann. Pharmacother. 43, 1324-1337 (2009).
8. Jackson, J., Fernandes, A. W. &Nelson, W. A naturalistic comparison of amoxicillin/ clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: a retrospective data analysis. Clin. Ther. 28, 1462-1471 (2006). (Pubitemid 44596292)
9. Gotfried, M. H. Clarithromycin (Biaxin) extended-release tablet: a therapeutic review. Expert Rev. Anti. Infect. Ther. 1, 9-20 (2003). (Pubitemid 38735727)
10. Thomas, J. K. et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob. Agents Chemother. 42, 521-527 (1998). (Pubitemid 28114802)
11. Talan, D. A., Naber, K. G., Palou, J. &Elkharrat, D. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections. Int. J. Antimicrob. Agents (23 Suppl 1), S54-66 (2004). (Pubitemid 38376050)
12. √ for Nontuberculous Mycobacteria. Insmed, City, (2011).
13. Robertson, S. Amoxicillin clinpharm pediatric review. City, (2007).
14. Alrazzak, L. A., Crampton, S. L., Gustavson, L. E., Hui, H., Milman, N. &Semla, S. Extended release formulations of clarithromycin. City, (2004).
15. Meyers, B. R. Cefaclor revisited. Clin. Ther. 22, 154-166 (2000). (Pubitemid 30152098)
16. Fleischer, A. B. Jr.,, Dinehart, S., Stough, D. &Plott, R. T. Safety and efficacy of a new extended-release formulation of minocycline. Cutis 78, 21-31 (2006). (Pubitemid 44720406)
17. Meers, P. et al. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J. Antimicrob. Chemother. 61, 859-868 (2008). (Pubitemid 351426071)
18. Anderson, E. M. et al. Sustained release of antibiotic from poly(2-hydroxyethyl methacrylate) to prevent blinding infections after cataract surgery. Biomaterials 30, 5675-5681 (2009).
19. Gupta, P., Vermani, K. &Garg, S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov. Today 7, 569-579 (2002). (Pubitemid 34603648)
20. Al-Kassas, R. S. &El-Khatib, M. M. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers. Drug Deliv. 16, 145-152 (2009).
21. Huang, S. &Fu, X. Naturally derived materials-based cell and drug delivery systems in skin regeneration. J. Control. Release 142, 149-159 (2010).
22. Kong, M., Chen, X. G., Xing, K. &Park, H. J. Antimicrobial properties of chitosan and mode of action: a state of the art review. Int. J. Food Microbiol. 144, 51-63 (2010).
23. Anal, A. K., Stevens, W. F. &Remunan-Lopez, C. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int. J. Pharm. 312, 166-173 (2006).
24. Hafeman, A. E. et al. Local delivery of tobramycin from injectable biodegradable polyurethane scaffolds. J. Biomater. Sci. Polym. Ed. 21, 95-112 (2010).
25. Li, B., Brown, K. V., Wenke, J. C. &Guelcher, S. A. Sustained release of vancomycin from polyurethane scaffolds inhibits infection of bone wounds in a rat femoral segmental defect model. J. Control. Release 145, 221-230 (2010).
26. Taylor, M. S., Daniels, A. U., Andriano, K. P. &Heller, J. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J. Appl. Biomater. 5, 151-157 (1994).
27. Kluin, O. S., van der Mei, H. C., Busscher, H. J. &Neut, D. A surface-eroding antibiotic delivery system based on poly-(trimethylene carbonate). Biomaterials 30, 4738-4742 (2009).
28. Dave, R. N., Joshi, H. M. &Venugopalan, V. P. Novel biocatalytic polymer based antimicrobial coatings as potential ureteral biomaterial: preparation and in vitro performance evaluation. Antimicrob Agents Chemother 55, 845-853 (2011).
29. Barrow, W. W. Microsphere technology for chemotherapy of mycobacterial infections. Curr. Pharm. Des. 10, 3275-3284 (2004). (Pubitemid 39276615)
30. Siepmann, F., Siepmann, J., Walther, M.,MacRae, R. J. &Bodmeier, R. Polymer blends for controlled release coatings. J. Control. Release 125, 1-15 (2008). (Pubitemid 350198680)
31. Li, H. &Chang, J. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. J. Control. Release 107, 463-473 (2005). (Pubitemid 41393355)
32. Xue, W., Liu, X., Zheng, X. &Ding, C. In vivo evaluation of plasma-sprayed wollastonite coating. Biomaterials 26, 3455-3460 (2005). (Pubitemid 40038139)
33. Schnieders, J., Gbureck, U., Thull, R. &Kissel, T. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 27, 4239-4249 (2006). (Pubitemid 44294361)
34. Liu, H. et al. Hydroxyapatite/polyurethane scaffold incorporated with drug-loaded ethyl cellulose microspheres for bone regeneration. J. Biomed. Mater. Res. B Appl. Biomater. 95, 36-46 (2010).
35. Adams, S. B. Jr,, Shamji, M. F., Nettles, D. L., Hwang, P. &Setton, L. A. Sustained release of antibiotics from injectable and thermally responsive polypeptide depots. J. Biomed. Mater. Res. B Appl. Biomater. 90, 67-74 (2009).
36. Elsner, J. J., Berdicevsky, I. &Zilberman, M. In vitro microbial inhibition and cellular response to novel biodegradable composite wound dressings with controlled release of antibiotics. Acta. Biomater. 7, 325-336 (2011).
37. Carlo Ceschel, G. et al. Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidine. Drug Dev. Ind. Pharm. 32, 53-61 (2006).
38. Keegan, G. et al. An in vitro assessment of bioadhesive zinc/carbomer complexes for antimicrobial therapy within the oral cavity. Int. J. Pharm. 340, 92-96 (2007). (Pubitemid 47043361)
39. Gates, K. A., Grad, H., Birek, P. &Lee, P. I. A new bioerodible polymer insert for the controlled release of metronidazole. Pharm. Res. 11, 1605-1609 (1994). (Pubitemid 24339682)
40. Chowdary, K. P. &Rao, Y. S. Mucoadhesive microspheres for controlled drug delivery. Biol. Pharm. Bull. 27, 1717-1724 (2004). (Pubitemid 41701593)
41. Govender, S. et al. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres. Int. J. Pharm. 306, 24-40 (2005). (Pubitemid 41643138)
42. Majithiya, R. J. &Murthy, R. S. Chitosan-based mucoadhesive microspheres of clarithromycin as a delivery system for antibiotic to stomach. Curr. Drug Deliv. 2, 235-242 (2005). (Pubitemid 40943995)
43. Gopinath, D., Kumar, M. S., Selvaraj, D. &Jayakumar, R. Pexiganan-incorporated collagen matrices for infected wound-healing processes in rat. J. Biomed. Mater. Res. A 73, 320-331 (2005). (Pubitemid 40664298)
44. Sripriya, R., Kumar, M. S., Ahmed, M. R. &Sehgal, P. K. Collagen bilayer dressing with ciprofloxacin, an effective system for infected wound healing. J. Biomater. Sci. Polym. Ed. 18, 335-351 (2007). (Pubitemid 46403140)
45. Karlgard, C. C., Jones, L. W. &Moresoli, C. Ciprofloxacin interaction with silicon-based and conventional hydrogel contact lenses. Eye Contact Lens 29, 83-89 (2003). (Pubitemid 43189073)
46. Venkatesh, S., Sizemore, S. P. &Byrne, M. E. Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics. Biomaterials 28, 717-724 (2007). (Pubitemid 44754878)
47. Ali, M. et al. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. J. Control. Release 124, 154-162 (2007). (Pubitemid 350110488)
48. Ciolino, J. B. et al. A drug-eluting contact lens. Invest. Ophthalmol. Vis. Sci. 50, 3346-3352 (2009).
49. Radin, S., El-Bassyouni, G., Vresilovic, E. J., Schepers, E. &Ducheyne, P. In vivo tissue response to resorbable silica xerogels as controlled-release materials. Biomaterials 26, 1043-1052 (2005). (Pubitemid 39208990)
50. Radin, S. &Ducheyne, P. Controlled release of vancomycin from thin sol-gel films on titanium alloy fracture plate material. Biomaterials 28, 1721-1729 (2007). (Pubitemid 46080466)
51. Adams, C. S. et al. Controlled release of vancomycin from thin sol-gel films on implant surfaces successfully controls osteomyelitis. J. Orthop. Res. 27, 701-709 (2009).
52. Chuang, H. F., Smith, R. C. &Hammond, P. T. Polyelectrolyte multilayers for tunable release of antibiotics. Biomacromolecules 9, 1660-1668 (2008). (Pubitemid 351954441)
53. Moskowitz, J. S. et al. The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model. Biomaterials 31, 6019-6030 (2010).
54. Wong, S. Y. et al. Dual functional polyelectrolyte multilayer coatings for implants: permanent microbicidal base with controlled release of therapeutic agents. J. Am. Chem. Soc. 132, 17840-17848 (2010).
55. Bilensoy, E. &Hincal, A. A. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Expert Opin. Drug Deliv. 6, 1161-1173 (2009).
56. Blanchemain, N. et al. Polyester vascular prostheses coated with a cyclodextrin polymer and activated with antibiotics: cytotoxicity and microbiological evaluation. Acta. Biomater. 4, 1725-1733 (2008).
57. Aleem, O., Kuchekar, B., Pore, Y. &Late, S. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. J. Pharm. Biomed. Anal. 47, 535-540 (2008).
58. Jianbin, C., Liang, C., Hao, X. &Dongpin, M. Preparation and study on the solid inclusion complex of ciprofloxacin with beta-cyclodextrin. Spectrochim. Acta. A Mol. Biomol. Spectrosc. 58, 2809-2815 (2002). (Pubitemid 35384767)
59. Young, R. M. et al. The results of in situ prosthetic replacement for infected aortic grafts. Am. J. Surg. 178, 136-140 (1999). (Pubitemid 29412955)
60. Blanchemain, N. et al. Vascular prostheses with controlled release of antibiotics Part 1: surface modification with cyclodextrins of PET prostheses. Biomol. Eng. 24, 149-153 (2007). (Pubitemid 46223547)
61. Blanchemain, N. et al. Methyl-beta-cyclodextrin modified vascular prosthesis: influence of the modification level on the drug delivery properties in different media. Acta. Biomater. 7, 304-314 (2011).
62. Domingues, Z. R. et al. Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with beta-cyclodextrin. Biomaterials 25, 327-333 (2004). (Pubitemid 37329722)
63. Xu, J., Li, X. &Sun, F. Cyclodextrin-containing hydrogels for contact lenses as a platform for drug incorporation and release. Acta. Biomater. 6, 486-493 (2010).
64. Hoste, K., De Winne, K. &Schacht, E. Polymeric prodrugs. Int. J. Pharm. 277, 119-131 (2004). (Pubitemid 38670427)
65. Jung, Y. &Kim, Y. M. Evaluation of cellulose xanthate-metal- tetracycline complexes as a polymeric antibacterial agent with prolonged antibacterial activity. Drug Deliv. 15, 31-35 (2008).
66. Imbuluzqueta, E. et al. Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections. Acta. Biomater. (2010).
67. Zhang, L., Pornpattananangku, D., Hu, C. M. &Huang, C. M. Development of nanoparticles for antimicrobial drug delivery. Curr. Med. Chem. 17, 585-594 (2010).
68. Zhang, L. et al. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83, 761-769 (2008). (Pubitemid 351556021)
69. Liu, P. F., Lo, C. W., Chen, C. H., Hsieh, M. F. &Huang, C. M. Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections. Curr. Drug Metab. 10, 875-884 (2009).
70. Kim, K. et al. Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. Biomacromolecules 6, 1154-1158 (2005). (Pubitemid 40467865)
71. Liu, C. G., Desai, K. G., Chen, X. G. &Park, H. J. Linolenic acid-modified chitosan for formation of self-assembled nanoparticles. J. Agric. Food Chem. 53, 437-441 (2005). (Pubitemid 40129938)
72. Hyung Park, J. et al. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials 27, 119-126 (2006).
73. Zhang, J., Chen, X. G., Li, Y. Y. &Liu, C. S. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomedicine 3, 258-265 (2007). (Pubitemid 350192330)
74. Peng, K. T. et al. Treatment of osteomyelitis with teicoplanin- encapsulated biodegradable thermosensitive hydrogel nanoparticles. Biomaterials 31, 5227-5236 (2010).
75. Rojanasakul, Y. et al. The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm. Res. 9, 1029-1034 (1992).
76. Dillen, K., Vandervoort, J., Van den Mooter, G. &Ludwig, A. Evaluation of ciprofloxacinloaded Eudragit RS100 or RL100/PLGA nanoparticles. Int. J. Pharm. 314, 72-82 (2006).
77. Das, S., Suresh, P. K. &Desmukh, R. Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine 6, 318-323 (2010).
78. Gupta, H., Aqil, M., Khar, R. K., Ali, A., Bhatnagar, A. &Mittal, G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine 6, 324-333 (2010).
79. Gupta, H. et al. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J. Drug Target. (2010).
80. Sung, J. C. et al. Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm. Res. 26, 1847-1855 (2009).
81. Liu, L. et al. Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. Biopolymers 90, 617-623 (2008).
82. Sharma, A., Sharma, S. &Khuller, G. K. Lectin-functionalized poly (lactide-coglycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. J. Antimicrob. Chemother. 54, 761-766 (2004). (Pubitemid 39386728)
83. Cheow, W. S., Chang, M. W. &Hadinoto, K. Antibacterial efficacy of inhalable levofloxacin-loaded polymeric nanoparticles against E. coli biofilm cells: the effect of antibiotic release profile. Pharm. Res. 27, 1597-1609 (2010).
84. Lecaroz, C., Gamazo, C. &Blanco-Prieto, M. J. Nanocarriers with gentamicin to treat intracellular pathogens. J. Nanosci. Nanotechnol. 6, 3296-3302 (2006). (Pubitemid 44580014)
85. Ferraz, M. P., Mateus, A. Y., Sousa, J. C. &Monteiro, F. J. Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts. J. Biomed. Mater. Res. A 81, 994-1004 (2007). (Pubitemid 46835096)
86. Huang, D. et al. Antibacterial chitosan coating on nano-hydroxyapatite/ polyamide66 porous bone scaffold for drug delivery. J. Biomater. Sci. Polym. Ed. 22, 931-944 (2010).
87. Zou, Q., Li, Y., Zhang, L., Zuo, Y. &Li, J. Antibiotic delivery system using nanohydroxyapatite/chitosan bone cement consisting of berberine. J. Biomed. Mater. Res. A 89, 1108-1117 (2009).
88. Hesaraki, S., Moztarzadeh, F., Nemati, R. &Nezafati, N. Preparation and characterization of calcium sulfate-biomimetic apatite nanocomposites for controlled release of antibiotics. J. Biomed. Mater. Res. B Appl. Biomater. 91, 651-661 (2009).
89. El-Ghannam, A., Ahmed, K. &Omran, M. Nanoporous delivery system to treat osteomyelitis and regenerate bone: gentamicin release kinetics and bactericidal effect. J. Biomed. Mater. Res. B Appl. Biomater. 73, 277-284 (2005). (Pubitemid 40628991)